Literature DB >> 15170814

Functional characterization of hepatoma-specific stem cell antigen-2.

Jin He1, Lung-Ji Chang.   

Abstract

Identification of tumor-specific antigens and genetic pathways may lead to potential diagnostic and therapeutic applications in cancer treatment. cDNA microarray has been used in cancer gene profiling, but the broad spectrum of data accruing and narrow signal-to-noise range of this technology have limited its use in rapid identification of highly differentially expressed tumor genes. Here, we used a modified suppression subtractive hybridization (SSH) method to isolate a small number of highly differentially expressed genes from murine hepatoma cells. For functional analysis of these hepatoma-specific genes, we employed the small interference RNA (siRNA)-mediated gene silencing method with lentiviral vectors, which have the advantages of high delivery efficiency and long lasting effect. Stem cell antigen-2 (Sca-2) was identified as one of the highest differentially expressed tumor antigens. Lentiviral siRNA successfully suppressed >90% of Sca-2 expression and the suppression lasted longer than 3 mo. Interestingly, inhibition of Sca-2 induced rapid hepatoma cell apoptosis, and the survival Sca-2-negative hepatoma cells exhibited high sensitivity to extrinsic tumor necrosis factor alpha (TNF-alpha) apoptosis signal but not intrinsic apoptosis signal. Analysis of TNF receptor 1 (TNFR1) by flow cytometry and Western blotting indicated that Sca-2 expression downregulated cell surface but not de novo synthesis of TNFR1 in the hepatoma cells. Together, our results suggested that Sca-2 was a signal transducer situated at the nexus of surface molecules regulating death receptor-mediated apoptosis. The technology illustrated that this method can deduce a small number of highly differentially expressed tumor genes that may have diagnostic and therapeutic potential. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170814     DOI: 10.1002/mc.20019

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  5 in total

1.  Cyclic di-GMP sensing via the innate immune signaling protein STING.

Authors:  Qian Yin; Yuan Tian; Venkataraman Kabaleeswaran; Xiaomo Jiang; Daqi Tu; Michael J Eck; Zhijian J Chen; Hao Wu
Journal:  Mol Cell       Date:  2012-06-14       Impact factor: 17.970

2.  Stem cell antigen 2: a new gene involved in the self-renewal of erythroid progenitors.

Authors:  C Bresson-Mazet; O Gandrillon; S Gonin-Giraud
Journal:  Cell Prolif       Date:  2008-10       Impact factor: 6.831

3.  An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens.

Authors:  Bei Wang; Jin He; Chen Liu; Lung-Ji Chang
Journal:  Vaccine       Date:  2006-02-28       Impact factor: 3.641

4.  Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells.

Authors:  Xiaochuan Chen; Jin He; Lung-Ji Chang
Journal:  Retrovirology       Date:  2004-11-01       Impact factor: 4.602

5.  LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis.

Authors:  Chan Joo Yeom; Lihua Zeng; Yoko Goto; Akiyo Morinibu; Yuxi Zhu; Kazumi Shinomiya; Minoru Kobayashi; Satoshi Itasaka; Michio Yoshimura; Cheol-Goo Hur; Hideaki Kakeya; Ester M Hammond; Masahiro Hiraoka; Hiroshi Harada
Journal:  Oncotarget       Date:  2016-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.